Sales Director - ADC & Oncology Biomarker Programs (Remote, US)

About Nucleai

There are 150+ ADCs in a hyper-competitive clinical pipeline, where success increasingly hinges on finding the right patients - and biomarker-led trials roughly double the probability of success from Phase 1 to BLA (~8% → ~16%). That's the problem Nucleai solves, with a track record across ADC clinical programs to prove it.

Nucleai is the AI-powered tissue-intelligence layer for biopharma drug development. We turn pathology into predictive biomarkers and QMS-grade clinical analysis - quantifying the tumor heterogeneity, spatial proximity, and bystander effect that current methods miss - with a delivery record across ADC trials and companion-diagnostic development. We help pharma teams identify ultra-responders, de-risk trial design, and win where it matters most: ADCs, radiopharmaceuticals, and bispecifics.

We're hiring a Director of Sales to own and grow this segment. This is a hunter-closer role. We already have strong pipeline and warm access at major accounts; the job is to convert those conversations into signed, scoped engagements - with people who already know and trust you.

What you'll do

• Close. Own signed bookings across ADC, radiopharma, and bispecific programs. Your number is contracts, not meetings.
• Convert relationships into scoped, paid engagements - moving deals from first conversation to signed SOW with our scientific and delivery teams.
• Bring and activate your network: engage translational, biomarker, and clinical-development leaders you already know, and turn them into pipeline fast.
• Run the full cycle with real qualification discipline - scoping, proposal, negotiation, close (we run MEDDIC).
• Be the internal commercial voice of the ADC market.

What you bring

• You take pride in closing - you measure yourself by deals signed, not doors opened, and you're energized by getting complex deals over the line.
• A warm ADC/oncology rolodex - current, trusted relationships with translational, biomarker, and clinical-development leaders at ADC developers. This is the role.
• 10+ years in sales, 5+ selling to pharma/biopharma, with a proven record in services and project-based engagements - not product or SaaS. You've sold bespoke, scoped analytical work the buyer has to envision before they buy (FMI, Tempus, NeoGenomics, CellCarta, or a CRO translational/biomarker unit is exactly right).
• A credible life-sciences foundation - you can hold a real conversation about tumor biology, biomarkers, and IHC, and translate the science into commercial value.
• Consultative selling, executive presence, and stamina for long, scientifically sophisticated cycles.

Why Nucleai

Work at the frontier of AI and precision oncology on some of the most important problems in drug development - with warm accounts to convert, science behind every conversation, and the autonomy to own this segment. Remote, US-based.

• Interested, or know someone who closes? Reach out directly. 🧬